Publication: Management of malaria in Thailand.
Issued Date
2002-01-01
Resource Type
ISSN
00234001
Other identifier(s)
2-s2.0-0036512099
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
The Korean journal of parasitology. Vol.40, No.1 (2002), 1-7
Suggested Citation
Udomsak Silachamroon, Srivicha Krudsood, Nanthaphorn Phophak, Sornchai Looareesuwan Management of malaria in Thailand.. The Korean journal of parasitology. Vol.40, No.1 (2002), 1-7. doi:10.3347/kjp.2002.40.1.1 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20228
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Management of malaria in Thailand.
Other Contributor(s)
Abstract
The purpose of treatment for uncomplicated malaria is to produce a radical cure using the combination of: artesunate (4 mg/kg/day) plus mefloquine (8 mg/kg day) for 3 days: a fixed dose of artemether and lumefantrine (20/120 mg tablet) named Coartem (4 tablets twice a day for three days for adults weighing more than 35 kg): quinine 10 mg/kg 8-hourly plus tetracycline 250 mg 6-hourly for 7 days (or doxycycline 200 mg as an alternative to tetracycline once a day for 7 days) in patients aged 8 years and over: Malarone (in adult 4 tablets daily for 3 days). In treating severe malaria, early diagnosis and treatment with a potent antimalarial drug is recommended to save the patient's life. The antimalarial drugs of choice are: intravenous quinine or a parenteral form of an artemisinin derivative (artesunate i.v./i.m. for 2.4 mg/kg followed by 1.2 mg/kg injection at 12 and 24 hr and then daily for 5 dayss; artemether i.m. 3.2 mg/kg injection followed by 1.6 mg/kg at 12 and 24 hrs and then daily for 5 days; artemether i.m. (Artemotil) with the same dose of artemether or artesunate suppository (5 mg/kg) given rectally 12 hourly for 3 days. Oral artemisinin derivatives (artesunate, artemether, and dihydroartemisinin with 4 mg/kg/day) could replace parenteral forms when patients can tolerate oral medication. Oral mefloquine (25 mg/kg divided into two doses 8 hrs apart) should be given at the end of the artemisinin treatment course to reduce recrudescence.